Attenuated Japanese encephalitis virus adapted to Vero cell and a Japanese encephalitis vaccine
Kim, H.S.; Yoo, W.D.; Kim, S.O.; Lee, S.H.; Moon, S.B.; Hong, S.P.; Shin, Y.C.; Chung, Y.J.; Eckels, K.H.; Innis, B.; Puniak, J.R.; Binn, L.N.; Srivastava, A.K.; Dubois, D.R.
Official Gazette of the United States Patent and Trademark Office Patents 1251(5)
2001
ISSN/ISBN: 0098-1133
Accession: 034457235
An attenuated Japanese encephalitis virus adapted to Vero cell by passages on Vero cell is disclosed. A Japanese encephalitis vaccine comprising said attenuated virus is also disclosed.
PDF emailed within 1 workday: $29.90
Related References
Kwon, H.J.; Kang, B.J.; Lim, Y.M.; Lee, C.K.; Jeon, Y.S. 1978: Studies on Japanese encephalitis live vaccine. V. Multiplication of Japanese encephalitis virus (Anyang strain) in chick embryo fibroblast and duck embryo fibroblast cell cultures. VI. Field application of Japanese encephalitis live virus (Anyang attenuated strain) vaccine. VII. Pathogenicity and immunogenicity in horses of the Anyang strain of attenuated virus Research Reports of the Office of Rural Development, Korea, Veterinary and Sericulture 20: 11-34Inoue, Y.K.; Iwasaki, T.; Kato, H. 1961: Studies on Japanese B encephalitis virus. I. Characteristics of mouse adapted and hamster kidney cell adapted Japanese B encephalitis viruses on plaque assay Journal of Immunology 87: 337-341
Ao, G.; Yu, Y.; Wu, P.; Li, H.; He, S.; Jia, R. 1981: Studies on mutation of japanese b encephalitis virus 7. an observation on persistence of immunity in children inoculated with japanese b encephalitis attenuated live vaccine sa 14 5 3 mutant Weishengwu Xuebao 21(4): 501-505
Bonaparte, M.; Dweik, B.; Feroldi, E.; Meric, C.; Bouckenooghe, A.; Hildreth, S.; Hu, B.; Yoksan, S.; Boaz, M. 2014: Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from south-east Asia and India Bmc Infectious Diseases 14: 156
Guirakhoo, F.; Zhang, Z.X.; Chambers, T.J.; Delagrave, S.; Arroyo, J.; Barrett, A.D.; Monath, T.P. 1999: Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis Virology 257(2): 363-372
Schuller, E.; Klade, C.S.; Heinz, F.X.; Kollaritsch, H.; Rendi-Wagner, P.; Jilma, B.; Tauber, E. 2008: Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51 Vaccine 26(48): 6151-6156
Gromowski, G.D.; Firestone, C.-Y.; Bustos-Arriaga, J.é; Whitehead, S.S. 2015: Genetic and phenotypic properties of vero cell-adapted Japanese encephalitis virus SA14-14-2 vaccine strain variants and a recombinant clone, which demonstrates attenuation and immunogenicity in mice American Journal of Tropical Medicine and Hygiene 92(1): 98-107
Yao ZhiHui; Dong GuanMu; Yu YongXin 1999: Study on a purified and inactivated Japanese encephalitis vaccine prepared on Vero cells using SA14-14-2 attenuated virus strain Chinese Journal of Experimental and Clinical Virology 13(2): 191-193
Yao, Z.; Dong, G.; Yu, Y. 1999: Study on a purified and inactivated Japanese encephalitis vaccine prepared on Vero cells using SA14-14-2 attenuated virus strain Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 13(2): 191-193
Kwon, H.J.; Kang, B.J.; Lim, Y.M.; Lee, C.K.; Jeon, Y.S. 1978: Japanese encephalitis live vaccine 6. field application of japanese encephalitis live virus anyang attenuated strain vaccine Research Reports of the Office of Rural Development (Suweon) 20(VET SER): 17-28
Yun, K.W.; Lee, H.J.; Kang, J.H.; Eun, B.W.; Kim, Y.-J.; Kim, K.-H.; Kim, N.H.; Hong, Y.J.; Kim, D.H.; Kim, H.M.; Cha, S.-H. 2015: Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC®) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: a phase III, multicenter, double-blinded, randomized trial Bmc Infectious Diseases 15: 7
Yasri, S.; Wiwanitkit, V. 2014: Finding of B cell epitope within polyprotein of Japanese encephalitis virus: a clue for development of new Japanese encephalitis vaccine Arquivos de Neuro-Psiquiatria 72(6): 478
Monath, T.P.; Guirakhoo, F.; Nichols, R.; Yoksan, S.; Schrader, R.; Murphy, C.; Blum, P.; Woodward, S.; McCarthy, K.; Mathis, D.; Johnson, C.; Bedford, P. 2003: Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen Journal of Infectious Diseases 188(8): 1213-1230
Monath, T.P.; Guirakhoo, F.; Johnson, C.; Bedford, P.; Nichols, R.; Yoksan, S.; Schrader, R.; Murphy, C.; Blum, P.; Woodward, S.; Mccarthy, K.; Mathis, D. 2003: Chimeric live, attenuated vaccine against Japanese encephalitis (Chimerivax-JE) : Phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen The Journal of Infectious Diseases 188(8): 1213-1230
Hammon, W.M. 1967: Vaccine control of the mosquito borne arboviruses excluding dengue and chikungunya viruses western equine encephalitis virus japanese b encephalitis cell cultures live attenuated human Japanese Journal of Medical Science and Biology 20(SUPP): 34-41
Takeshita, N.; Lim, C.-K.; Mizuno, Y.; Shimbo, T.; Kotaki, A.; Ujiie, M.; Hayakawa, K.; Kato, Y.; Kanagawa, S.; Kaku, M.; Takasaki, T. 2014: Immunogenicity of single-dose Vero cell-derived Japanese encephalitis vaccine in Japanese adults Journal of Infection and Chemotherapy: Official Journal of the Japan Society of ChemoTherapy 20(4): 238-242
Sumiyoshi, H.; Hoke, C.H.Jr 1998: Infectious Japanese encephalitis virus cDNA clones that produce highly attenuated recombinant Japanese encephalitis virus, and vaccines thereof Official Gazette of the United States Patent and Trademark Office Patents 1209(1): 400
Xu, Y.; Wang, Q.; Wei, B.; Huang, X.; Wen, Y.; Yan, Q.; Ma, X.; Zhao, Q.; Cao, S.; Huang, Y.; Wen, X.; Han, X.; Bai, Y.; Wu, R. 2019: Enhanced Immune Responses Against Japanese Encephalitis Virus Infection Using Japanese Encephalitis Live-Attenuated Virus Adjuvanted with Montanide GEL 01 ST in Mice Vector Borne and Zoonotic Diseases 19(11): 835-843
Xu, Y.; Wang, Q.; Wei, B.; Huang, X.; Wen, Y.; Yan, Q.; Ma, X.; Zhao, Q.; Cao, S.; Huang, Y.; Wen, X.; Han, X.; Bai, Y.; Wu, R. 2019: Enhanced Immune Responses Against Japanese Encephalitis Virus Infection Using Japanese Encephalitis Live-Attenuated Virus Adjuvanted with Montanide Gel 01 St in Mice Vector-Borne and Zoonotic Diseases
Schuller, E.; Klingler, A.; Dubischar-Kastner, K.; Dewasthaly, S.; Müller, Z. 2011: Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO(®) Vaccine 29(47): 8669-8676